Drug: SERETIDE Injury: Chronic obstructive pulmonary disease Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
106747443 | SERETIDE | Chronic obstructive pulmonary disease | NOVARTIS | 63.87 YR | M | 71 KG | 20160909 | DE |
125209181 | SERETIDE | Chronic obstructive pulmonary disease | GLAXOSMITHKLINE | 67.00 YR | F | 65 KG | 20160701 | CN |
125440541 | SERETIDE | Chronic obstructive pulmonary disease | GLAXOSMITHKLINE | 0.00 | M | 0 | 20160711 | JP |
125581924 | SERETIDE | Chronic obstructive pulmonary disease | GLAXOSMITHKLINE | 64.00 YR | M | 0 | 20160825 | CN |
126341361 | SERETIDE | Chronic obstructive pulmonary disease | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160809 | AR |
127045141 | SERETIDE | Chronic obstructive pulmonary disease | GLAXOSMITHKLINE | 89.82 YR | F | 0 | 20160831 | BR |
Total Records: 6 Number of Pages: 1